Seminars in Oncology
Volume 33, Supplement 11 , Pages 24-27, December 2006

Successful Gastrointestinal Cancer Drug Development

  • J. Randolph Hecht

      Affiliations

    • Corresponding Author InformationAddress reprint requests to J. Randolph Hecht, MD, UCLA GI Oncology Program, UCLA School of Medicine, 2338G PVUB, 10945 Le Conte Ave, Los Angeles, CA 90095, USA

University of California–Los Angeles GI Oncology Program, UCLA School of Medicine, Los Angeles, CA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Hecht has received research grant support from Amgen, Novartis, Roche, and Genvec, and has served as a consultant to Genentech.

PII: S0093-7754(06)00378-2

doi:10.1053/j.seminoncol.2006.10.001

Seminars in Oncology
Volume 33, Supplement 11 , Pages 24-27, December 2006

Article Tools

* Image Usage & Resolution